Close Menu

NEW YORK (GenomeWeb) – Curetis said today that its subsidiary Ares Genetics has entered into a licensing agreement with Qiagen for Ares' bioinformatics tools for antimicrobial resistance (AMR) research.

Under the agreement Qiagen has received an exclusive license to develop and commercialize general bioinformatics offerings and services for AMR research based on ARESdb, a database containing genetic information on AMR, and AREStools, a bioinformatics toolbox.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.

Jun
17
Sponsored by
Illumina

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.